Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial - Daniel Franjic; Robert J. Fountaine; Catherine Nalpas; Budhaditya Goswami; Terence Fullerton (PLoS ONE, 2026)